Antiviral drug resistance: Mechanisms and clinical implications

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Antiviral drug resistance is an increasing concern in immunocompromised patient populations, where ongoing viral replication and prolonged drug exposure lead to the selection of resistant strains. Rapid diagnosis of resistance can be made by associating characteristic viral mutations with resistance to various drugs as determined by phenotypic assays. Management of drug resistance includes optimization of host factors and drug delivery, selection of alternative therapies based on knowledge of mechanisms of resistance, and the development of new antivirals. This article discusses drug resistance in herpesviruses and hepatitis B.

Original languageEnglish (US)
Pages (from-to)809-833
Number of pages25
JournalInfectious Disease Clinics of North America
Volume24
Issue number3
DOIs
StatePublished - 2010

Fingerprint

Viral Drug Resistance
Drug Resistance
Pharmaceutical Preparations
Cercopithecine Herpesvirus 1
Immunocompromised Host
Complementary Therapies
Hepatitis B
Antiviral Agents
Mutation
Population

Keywords

  • Cytomegalovirus
  • Drug resistance
  • Hepatitis B virus
  • Herpes simplex virus
  • Transplant
  • Varicella zoster virus

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases
  • Medicine(all)

Cite this

Antiviral drug resistance : Mechanisms and clinical implications. / Strasfeld, Lynne; Chou, Sunwen.

In: Infectious Disease Clinics of North America, Vol. 24, No. 3, 2010, p. 809-833.

Research output: Contribution to journalArticle

@article{96b78f749845411497556dc0be6c64e8,
title = "Antiviral drug resistance: Mechanisms and clinical implications",
abstract = "Antiviral drug resistance is an increasing concern in immunocompromised patient populations, where ongoing viral replication and prolonged drug exposure lead to the selection of resistant strains. Rapid diagnosis of resistance can be made by associating characteristic viral mutations with resistance to various drugs as determined by phenotypic assays. Management of drug resistance includes optimization of host factors and drug delivery, selection of alternative therapies based on knowledge of mechanisms of resistance, and the development of new antivirals. This article discusses drug resistance in herpesviruses and hepatitis B.",
keywords = "Cytomegalovirus, Drug resistance, Hepatitis B virus, Herpes simplex virus, Transplant, Varicella zoster virus",
author = "Lynne Strasfeld and Sunwen Chou",
year = "2010",
doi = "10.1016/j.idc.2010.07.001",
language = "English (US)",
volume = "24",
pages = "809--833",
journal = "Infectious Disease Clinics of North America",
issn = "0891-5520",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Antiviral drug resistance

T2 - Mechanisms and clinical implications

AU - Strasfeld, Lynne

AU - Chou, Sunwen

PY - 2010

Y1 - 2010

N2 - Antiviral drug resistance is an increasing concern in immunocompromised patient populations, where ongoing viral replication and prolonged drug exposure lead to the selection of resistant strains. Rapid diagnosis of resistance can be made by associating characteristic viral mutations with resistance to various drugs as determined by phenotypic assays. Management of drug resistance includes optimization of host factors and drug delivery, selection of alternative therapies based on knowledge of mechanisms of resistance, and the development of new antivirals. This article discusses drug resistance in herpesviruses and hepatitis B.

AB - Antiviral drug resistance is an increasing concern in immunocompromised patient populations, where ongoing viral replication and prolonged drug exposure lead to the selection of resistant strains. Rapid diagnosis of resistance can be made by associating characteristic viral mutations with resistance to various drugs as determined by phenotypic assays. Management of drug resistance includes optimization of host factors and drug delivery, selection of alternative therapies based on knowledge of mechanisms of resistance, and the development of new antivirals. This article discusses drug resistance in herpesviruses and hepatitis B.

KW - Cytomegalovirus

KW - Drug resistance

KW - Hepatitis B virus

KW - Herpes simplex virus

KW - Transplant

KW - Varicella zoster virus

UR - http://www.scopus.com/inward/record.url?scp=77955251899&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955251899&partnerID=8YFLogxK

U2 - 10.1016/j.idc.2010.07.001

DO - 10.1016/j.idc.2010.07.001

M3 - Article

C2 - 20674805

AN - SCOPUS:77955251899

VL - 24

SP - 809

EP - 833

JO - Infectious Disease Clinics of North America

JF - Infectious Disease Clinics of North America

SN - 0891-5520

IS - 3

ER -